SSY Group Limited (HKG:2005)

Market Cap	8.53B
Revenue (ttm)	5.77B
Net Income (ttm)	1.06B
Shares Out	2.95B
EPS (ttm)	0.36
PE Ratio	8.07
Forward PE	7.28
Dividend	0.18 (6.06%)
Ex-Dividend Date	May 20, 2025

Volume	10,470,000
Average Volume	6,180,150
Open	2.890
Previous Close	2.890
Day's Range	2.860 - 2.920
52-Week Range	2.860 - 4.970
Beta	0.63
RSI	37.40
Earnings Date	Aug 28, 2025

About SSY Group

SSY Group Limited, an investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk phar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 6,146
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2005

Financial Performance

In 2024, SSY Group's revenue was 5.77 billion, a decrease of -10.67% compared to the previous year's 6.46 billion. Earnings were 1.06 billion, a decrease of -19.53%.